proxyvotesnow.com

Home › Asset managers › Principal Exchange-Traded Funds › 2023-2024 › Against the board

Principal Exchange-Traded Funds 2023-2024: where it broke with the board

Two kinds of vote are listed: a board-sponsored proposal Principal Exchange-Traded Funds voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.

Everything Only shareholder proposals it backed

805 proposals.

Principal Exchange-Traded Funds, 2023-2024 proxy season. Who put a proposal on the ballot is taken from the filer’s own N-PX answer (Item 1(h)), or, marked “inferred”, from its category and wording where the filing does not say; see how we count these.
CompanyMeetingProposalCategory On the ballot fromBoard recommendedPrincipal Exchange-Traded Funds votedFunds
ZENTALIS PHARMACEUTICALS INC. June 21, 2024 Election of Class I Directors to serve until the 2027 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified, subject to their earlier death, resignation or removal: Kimberly Blackwell, M.D. Director Elections Board WITHHOLD 1
ZENTALIS PHARMACEUTICALS INC. June 21, 2024 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. Say-on-Pay Board AGAINST 1
ZIPRECRUITER INC. June 11, 2024 Election of Class III Directors for three-year term: Blake Irving Director Elections Board WITHHOLD 1
ZIPRECRUITER INC. June 11, 2024 Election of Class III Directors for three-year term: Emily McEvilly Director Elections Board WITHHOLD 1
ZYNEX INC. May 16, 2024 Election of Directors: Joshua R. Disbrow Director Elections Board WITHHOLD 1

← Previous Page 9 of 9

← Back to Principal Exchange-Traded Funds 2023-2024 overview

Built October 12, 2026 from SEC Form N-PX filings.